AUA2019 048IC Novel Agents & Concepts In The Management Of Hormone Naïve & CRPC
AUAUniversity12 Heinä 2019

AUA2019 048IC Novel Agents & Concepts In The Management Of Hormone Naïve & CRPC

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: https://auau.auanet.org/content/novel-agents-concepts-management-hormone-na%C3%AFve-castrate-resistant-prostate-cancer-webcast-0 This course will include short didactic lectures followed by case presentations to give attendees an understanding of the many new FDA-approved agents, as well as existing standard therapies, for advanced prostate cancer-both non-metastatic and metastatic CRPC. Particular attention will be devoted to sequencing the new agents and positioning them as compared to older existing therapies. The cost effectiveness of new and existing agents will also be addressed. Learning Objectives: Diagnose both non-metastatic and metastatic castrate resistant prostate cancer (nmCRPC, mCRPC) and have a working knowledge of treatments and the proper order for administration. Manage nm and mCRPC with systemic agents by learning the proper candidates for treatment and be able to counsel patients on the pros and cons of therapy. Analyze the mechanism of action and risks/benefits of using systemic agents in the treatment of nm/mCRPC. Describe the bone-targeted, radiopharmaceutical agent and its sequencing. Review the newer generation antiandrogen agents and their use in nmCRPC and in mCRPC.

Jaksot(421)

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer is the second in the 4-part series. Topics will include "non muscle invasive disease" and "muscle invasive disease" as well as "clinical trial evidence" and ...

24 Loka 201854min

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

Speakers: Christopher M. Gonzalez, MD, MBA James M. Dupree, MD, MPH

22 Loka 201817min

Incorporating New IO Therapies - Managing Patient Side Effects

Incorporating New IO Therapies - Managing Patient Side Effects

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

19 Loka 201830min

Immuno - Oncoloy: A New Class Of Drugs

Immuno - Oncoloy: A New Class Of Drugs

Immuno-Oncology: A New Class of Drugs is the first in the 4-part series. Topics will include "Tumor Immunotherapy", "Immunotherapy Drug Availability and Mechanisms of Action", "Vaccines", "Monoclonal ...

10 Loka 201842min

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer: What's New is the third podcast in a 4-part series. Topics will include "Manipulating the Androgen Axis: Androgen Biosynthe...

8 Loka 201856min

Incorporating New IO Therapies - Biomarkers

Incorporating New IO Therapies - Biomarkers

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

4 Loka 201829min

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation are producing a serie...

28 Syys 201851min

AUA2018 Take Home Messages - Infertility Andrology And Sexual Dysfunction

AUA2018 Take Home Messages - Infertility Andrology And Sexual Dysfunction

Take Home Messages from AUA2018 Infertility / Andrology Lawrence Jenkins, MD, MBA The Ohio State University Sexual Dysfunction Nelson Bennett, Jr., MD, FACS Northwestern University Feinberg School o...

26 Syys 201819min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-valo-minussa-2
rss-duodecim-lehti
aamukahvilla
jari-sarasvuo-podcast
psykologia
salainen-paivakirja
leveli
rss-uskonto-on-tylsaa
rss-luonnollinen-synnytys-podcast
rss-tietoinen-yhteys-podcast-2
rss-koira-haudattuna
rss-arkea-ja-aurinkoa-podcast-espanjasta
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-hereilla